Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 41


Canine H3N8 influenza vaccines partially protect mice against the canine H3N2 strain currently circulating in the United States.

Willis E, Parkhouse K, Krammer F, Hensley SE.

Vaccine. 2016 Sep 23. pii: S0264-410X(16)30830-1. doi: 10.1016/j.vaccine.2016.09.017. [Epub ahead of print]


Characterization of Femoral Component Initial Stability and Cortical Strain in a Reduced Stem-Length Design.

Small SR, Hensley SE, Cook PL, Stevens RA, Rogge RD, Meding JB, Berend ME.

J Arthroplasty. 2016 Aug 10. pii: S0883-5403(16)30457-0. doi: 10.1016/j.arth.2016.07.033. [Epub ahead of print]


Antibodies with 'Original Antigenic Sin' Properties Are Valuable Components of Secondary Immune Responses to Influenza Viruses.

Linderman SL, Hensley SE.

PLoS Pathog. 2016 Aug 18;12(8):e1005806. doi: 10.1371/journal.ppat.1005806. eCollection 2016 Aug.


Cutting Edge: IL-4, IL-21, and IFN-γ Interact To Govern T-bet and CD11c Expression in TLR-Activated B Cells.

Naradikian MS, Myles A, Beiting DP, Roberts KJ, Dawson L, Herati RS, Bengsch B, Linderman SL, Stelekati E, Spolski R, Wherry EJ, Hunter C, Hensley SE, Leonard WJ, Cancro MP.

J Immunol. 2016 Aug 15;197(4):1023-8. doi: 10.4049/jimmunol.1600522. Epub 2016 Jul 18.


Propagation and Characterization of Influenza Virus Stocks That Lack High Levels of Defective Viral Genomes and Hemagglutinin Mutations.

Xue J, Chambers BS, Hensley SE, López CB.

Front Microbiol. 2016 Mar 23;7:326. doi: 10.3389/fmicb.2016.00326. eCollection 2016.


Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season.

Chambers BS, Parkhouse K, Ross TM, Alby K, Hensley SE.

Cell Rep. 2015 Jul 7;12(1):1-6. doi: 10.1016/j.celrep.2015.06.005. Epub 2015 Jun 25.


Multiplexed detection of viral infections using rapid in situ RNA analysis on a chip.

Shaffer SM, Joshi RP, Chambers BS, Sterken D, Biaesch AG, Gabrieli DJ, Li Y, Feemster KA, Hensley SE, Issadore D, Raj A.

Lab Chip. 2015 Aug 7;15(15):3170-82. doi: 10.1039/c5lc00459d.


Novel synthetic plasmid and Doggybone DNA vaccines induce neutralizing antibodies and provide protection from lethal influenza challenge in mice.

Scott VL, Patel A, Villarreal DO, Hensley SE, Ragwan E, Yan J, Sardesai NY, Rothwell PJ, Extance JP, Caproni LJ, Weiner DB.

Hum Vaccin Immunother. 2015;11(8):1972-82. doi: 10.1080/21645515.2015.1022008.


RNASEK is required for internalization of diverse acid-dependent viruses.

Hackett BA, Yasunaga A, Panda D, Tartell MA, Hopkins KC, Hensley SE, Cherry S.

Proc Natl Acad Sci U S A. 2015 Jun 23;112(25):7797-802. doi: 10.1073/pnas.1424098112. Epub 2015 Jun 8.


HSV-1 remodels host telomeres to facilitate viral replication.

Deng Z, Kim ET, Vladimirova O, Dheekollu J, Wang Z, Newhart A, Liu D, Myers JL, Hensley SE, Moffat J, Janicki SM, Fraser NW, Knipe DM, Weitzman MD, Lieberman PM.

Cell Rep. 2014 Dec 24;9(6):2263-78. doi: 10.1016/j.celrep.2014.11.019. Epub 2014 Dec 11.


Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season.

Linderman SL, Chambers BS, Zost SJ, Parkhouse K, Li Y, Herrmann C, Ellebedy AH, Carter DM, Andrews SF, Zheng NY, Huang M, Huang Y, Strauss D, Shaz BH, Hodinka RL, Reyes-Terán G, Ross TM, Wilson PC, Ahmed R, Bloom JD, Hensley SE.

Proc Natl Acad Sci U S A. 2014 Nov 4;111(44):15798-803. doi: 10.1073/pnas.1409171111. Epub 2014 Oct 20.


Editorial overview: viral evolution: exploring the frontiers of virus evolution in the lab, the field and the clinic.

Brockhurst MA, Hensley SE.

Curr Opin Virol. 2014 Oct;8:ix-x. doi: 10.1016/j.coviro.2014.09.002. Epub 2014 Sep 13. No abstract available.


Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories.

Hensley SE.

Curr Opin Virol. 2014 Oct;8:85-9. doi: 10.1016/j.coviro.2014.07.007. Epub 2014 Aug 11. Review.


Coinfection with Streptococcus pneumoniae modulates the B cell response to influenza virus.

Wolf AI, Strauman MC, Mozdzanowska K, Whittle JR, Williams KL, Sharpe AH, Weiser JN, Caton AJ, Hensley SE, Erikson J.

J Virol. 2014 Oct;88(20):11995-2005. doi: 10.1128/JVI.01833-14. Epub 2014 Aug 6.


Pneumolysin expression by streptococcus pneumoniae protects colonized mice from influenza virus-induced disease.

Wolf AI, Strauman MC, Mozdzanowska K, Williams KL, Osborne LC, Shen H, Liu Q, Garlick D, Artis D, Hensley SE, Caton AJ, Weiser JN, Erikson J.

Virology. 2014 Aug;462-463:254-65. doi: 10.1016/j.virol.2014.06.019. Epub 2014 Jul 5.


Recent H3N2 influenza virus clinical isolates rapidly acquire hemagglutinin or neuraminidase mutations when propagated for antigenic analyses.

Chambers BS, Li Y, Hodinka RL, Hensley SE.

J Virol. 2014 Sep;88(18):10986-9. doi: 10.1128/JVI.01077-14. Epub 2014 Jul 2.


Antigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines.

Jiang J, Fisher EM, Hensley SE, Lustigman S, Murasko DM, Shen H.

Vaccine. 2014 May 13;32(23):2696-702. doi: 10.1016/j.vaccine.2014.03.046. Epub 2014 Mar 26.


Compensatory hemagglutinin mutations alter antigenic properties of influenza viruses.

Myers JL, Wetzel KS, Linderman SL, Li Y, Sullivan CB, Hensley SE.

J Virol. 2013 Oct;87(20):11168-72. doi: 10.1128/JVI.01414-13. Epub 2013 Aug 7.


Immune history shapes specificity of pandemic H1N1 influenza antibody responses.

Li Y, Myers JL, Bostick DL, Sullivan CB, Madara J, Linderman SL, Liu Q, Carter DM, Wrammert J, Esposito S, Principi N, Plotkin JB, Ross TM, Ahmed R, Wilson PC, Hensley SE.

J Exp Med. 2013 Jul 29;210(8):1493-500. doi: 10.1084/jem.20130212. Epub 2013 Jul 15.


Single hemagglutinin mutations that alter both antigenicity and receptor binding avidity influence influenza virus antigenic clustering.

Li Y, Bostick DL, Sullivan CB, Myers JL, Griesemer SB, Stgeorge K, Plotkin JB, Hensley SE.

J Virol. 2013 Sep;87(17):9904-10. doi: 10.1128/JVI.01023-13. Epub 2013 Jul 3.

Items per page

Supplemental Content

Loading ...
Support Center